Literature DB >> 15932911

Irregular cycles and steroid hormones in polycystic ovary syndrome.

Suhail A R Doi1, Mona Al-Zaid, Philip A Towers, Christopher J Scott, Kamal A S Al-Shoumer.   

Abstract

BACKGROUND: This cross-sectional study was undertaken to evaluate the factors that relate to menstrual status (oligo-amenorrhoea versus eumenorrhoea) in polycystic ovary syndrome (PCOS).
METHODS: A total of 234 women with clinical and biochemical features suggestive of PCOS underwent metabolic and hormonal evaluation. A forward stepwise logistic regression model was created based on the results to determine variables related to ovulatory status.
RESULTS: Only follicular phase progesterone and estradiol (E(2)) were retained in the final model. This model correctly classified 80% of PCOS women by ovulatory status. Univariate analysis revealed no difference in progesterone between ovulatory groups but E(2) was higher in anovulatory groups. This suggested interaction between progesterone and E(2) and the single interaction variable (progesterone/E(2)) also classified 80% of women by ovulatory status correctly.
CONCLUSION: The results suggest that a low ratio of progesterone to E(2) is associated with menstrual irregularity and ovulatory status in PCOS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15932911     DOI: 10.1093/humrep/dei093

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  12 in total

Review 1.  Neuroendocrine dysfunction in PCOS: a critique of recent reviews.

Authors:  Suhail A R Doi
Journal:  Clin Med Res       Date:  2008-09

2.  Ovarian steroids modulate neuroendocrine dysfunction in polycystic ovary syndrome.

Authors:  S A R Doi; M Al-Zaid; P A Towers; C J Scott; K A S Al-Shoumer
Journal:  J Endocrinol Invest       Date:  2005-11       Impact factor: 4.256

3.  Polycystic ovary syndrome and risk of uterine leiomyomata.

Authors:  Lauren A Wise; Julie R Palmer; Elizabeth A Stewart; Lynn Rosenberg
Journal:  Fertil Steril       Date:  2007-01-22       Impact factor: 7.329

4.  Pre-pregnancy maternal fasting plasma glucose levels in relation to time to pregnancy among the couples attempting first pregnancy.

Authors:  Jun Zhao; Xiang Hong; Hongguang Zhang; Qiaoyun Dai; Kaiping Huang; Xu Zhang; Yuxiang Liu; Jingwei Wu; Qiaomei Wang; Haiping Shen; Zongyu Xu; Yiping Zhang; Donghai Yan; Daxun Qi; Xueying Yang; Yue Zhang; Bei Wang; Xu Ma
Journal:  Hum Reprod       Date:  2019-07-08       Impact factor: 6.918

5.  Quercetin and polycystic ovary syndrome, current evidence and future directions: a systematic review.

Authors:  Fatemeh Pourteymour Fard Tabrizi; Fatemeh Hajizadeh-Sharafabad; Maryam Vaezi; Hamed Jafari-Vayghan; Mohammad Alizadeh; Vahid Maleki
Journal:  J Ovarian Res       Date:  2020-01-31       Impact factor: 4.234

6.  Apigenin exerts protective effect and restores ovarian function in dehydroepiandrosterone induced polycystic ovary syndrome rats: a biochemical and histological analysis.

Authors:  Fangxin Peng; Yichuan Hu; Shu Peng; Ni Zeng; Lei Shi
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709

7.  The association between the pre-pregnancy vaginal microbiome and time-to-pregnancy: a Chinese pregnancy-planning cohort study.

Authors:  Xiang Hong; Jun Zhao; Jiechen Yin; Fanqi Zhao; Wei Wang; Xiaoling Ding; Hong Yu; Xu Ma; Bei Wang
Journal:  BMC Med       Date:  2022-08-01       Impact factor: 11.150

8.  Psychological disturbances and quality of life in obese and infertile women and men.

Authors:  Piotr Kocełak; Jerzy Chudek; Beata Naworska; Monika Bąk-Sosnowska; Barbara Kotlarz; Monika Mazurek; Paweł Madej; Violetta Skrzypulec-Plinta; Piotr Skałba; Magdalena Olszanecka-Glinianowicz
Journal:  Int J Endocrinol       Date:  2012-07-16       Impact factor: 3.257

9.  The mechanism of mTOR (mammalian target of rapamycin) in a mouse model of polycystic ovary syndrome (PCOS).

Authors:  Aylin Yaba; Necdet Demir
Journal:  J Ovarian Res       Date:  2012-11-27       Impact factor: 4.234

10.  Therapeutic potentials of Quercetin in management of polycystic ovarian syndrome using Letrozole induced rat model: a histological and a biochemical study.

Authors:  Sarwat Jahan; Abira Abid; Sidra Khalid; Tayyaba Afsar; Ghazala Shaheen; Ali Almajwal; Suhail Razak
Journal:  J Ovarian Res       Date:  2018-04-03       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.